Skip to main content

Table 3 Factors associated with viral load rebound among PLHIV on ART between 2016 to 2020 in Northern Tanzania (N = 310)

From: HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania

Characteristics

Unadjusted

p-value

Adjusted

p-value

 

RR (95% CI)

 

RR (95% CI)

 

Age group (in years)

    

6–14

1.00

 

1.00

 

15–24

1.1 (0.60–2.01)

0.757

1.29 (0.61–2.76)

0.505

25–54

0.61 (0.38–0.98)

0.042

0.89 (0.47–1.69)

0.726

55+

0.56 (0.32–0.97)

0.039

0.86 (0.42–1.76)

0.682

Sex

    

Male

1.00

 

1.00

 

Female

0.86 (0.65–1.12)

0.265

0.86 (0.65–1.13)

0.280

Marital status

    

Single

1.00

 

-

 

Cohabiting/Married

0.89 (0.65–1.23)

0.481

  

Divorced/Separated

0.81 (0.53–1.23)

0.318

  

HIV Stage

    

Stage I

1.00

 

1.00

 

Stage II

0.73 (0.46–1.14)

0.162

0.72 (0.46–1.13)

0.155

Stage III

1.04 (0.73–1.48)

0.813

0.98 (0.69–1.39)

0.907

Stage IV

1.25 (0.79 (1.98)

0.335

1.11 (0.70–1.76)

0.657

*BMI (kg/m2)

    

Underweight

1.33 (0.84–2.12)

0.218

1.31 (0.81–2.12)

0.264

Normal

1.00

   

Overweight

1.28 (0.92–1.79)

0.147

1.22 (0.87–1.72)

0.241

Obesity

1.12 (0.78–1.61)

0.536

1.18 (0.82–1.70)

0.368

ART regimen

    

First line

0.52 (0.34–0.79)

0.003

0.72 (0.38–1.36)

0.314

Second line

1.00

 

1.00

 

Treatment supporter visit

    

No

1.00

 

1.00

 

Yes

0.84 (0.57–1.22)

0.360

0.77 (0.51–1.15)

0.205

ART adherence

    

Poor

1.00

 

1.00

 

Good

0.79 (0.44–1.42)

0.434

0.79 (0.47–1.32)

0.361

*Visit status

    

1–2

1.00

 

1.00

 

3

0.59 (0.41–0.85)

0.005

0.64 (0.44–0.93)

0.019

4–6

0.87 (0.62–1.17)

0.307

0.87 (0.63–1.20)

0.397

  1. Key RR; Relative risk, 1: Reference.* Visits status is defined as number of visits done per year. E.g.; 1–2 the person, went to the clinic after every 6–12months.*BMI= Current BMI